Cordée wishes you a happy holiday season. See you in 2020!...
BLOG


- Dec 18, 2019
Nur-Sultan, Kazakhstan: Well on the way to an effective HTA process...

- Dec 12, 2019
Health Technology Assessment: Cost-effectiveness thresholds vary and are rarely explicit...

- Dec 11, 2019
Vienna School of Clinical Research: Health Technology Assessment goes Kazakhstan

- Nov 28, 2019
EU regulatory pathways (II): all processes lead to Market Authorization decisions...

- Nov 28, 2019
EU regulatory pathways (I): All pathways lead to...

- Nov 20, 2019
The evolution of reimbursement: evidence based medicine wins over non-proven therapeutics

- Nov 13, 2019
Scientific communication (2): does your narrative reach opinion makers?

- Nov 13, 2019
Scientific communication (1): do you monitor what they say about you?

- Oct 30, 2019
Different systems have different HTA needs

- Oct 24, 2019
German healthcare system October 2019*: increasing number of non available prescription drugs: drive

- Oct 17, 2019
Biosimilars: automatic substitution rules create new doctor - patient interaction challenges.

- Oct 10, 2019
Biosimilars: Are reference analogs and biosimilars interchangeable?

- Oct 2, 2019
Pharmaceutical innovation: what’s the deal and what are outcome assumptions…

- Sep 19, 2019
VSCR-SFU Health outcome research course- evidence-based decision making for pricing and reimbursemen

- Sep 15, 2019
Technology is there to help enable more meaningful and empathic patient-doctor relationships...

- Sep 4, 2019
AI and big data are big in big pharma...

- Aug 30, 2019
The family tree of pharmaceutical pricing is in full bloom...